Radiopharmaceuticals
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
90
NCT06139575
Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer
Phase: Phase 1/2
Role: Lead Sponsor
Start: Dec 22, 2023
Completion: Jul 31, 2027
Loading map...